Format

Send to

Choose Destination
Rev Prat. 2013 Jan;63(1):68-73.

[Therapeutic innovation in AMD and other retinal diseases].

[Article in French]

Author information

1
Université Pierre-et-Marie-Curie, Paris-6, France.

Abstract

Age-related macular degeneration (AMD) is a leading cause of severe visual impairment in individuals over 50 years in developed countries. Latest advances in imaging techniques have led to improved and accurate diagnosis of AMD. We witness a major breakthrough in the treatment of the neovascular form of AMD with the antiangiogenic (anti-VEGF) drugs. However, no therapy is yet available for the atrophic dry form of AMD. Innovative strategies gene therapy, cell therapy, nanotechnology neuroprotection- and multidisciplinary approaches are emerging to prevent the decline in vision in aging populations and its health implications.

PMID:
23457831
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center